ACAD:NASDAQ
ACADIA Pharmaceuticals Inc
$18.99
arrow_upward
+1.99%(+0.37) 1D
Oct 14, 9:52:09 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ACAD...
Open
$18.60
High
$19.06
Low
$18.49
Mkt. cap
3.27B
Avg. vol.
2.13M
Volume
25.71K
P/E ratio
8.58
52-wk high
$30.96
52-wk low
$18.39
EPS
$2.21
Beta
0.89
Shares outstanding
172.31M
No. of employees
797
Open
$18.60
High
$19.06
Low
$18.49
Mkt. cap
3.27B
Avg. vol.
2.13M
Volume
25.71K
P/E ratio
8.58
52-wk high
$30.96
52-wk low
$18.39
EPS
$2.21
Beta
0.89
Shares outstanding
172.31M
No. of employees
797
News stories
From web sources and news partners
GuruFocus
·
15 hours ago
ACAD Downgraded by UBS -- Price Target Lowered to $23.00
TipRanks
·
19 hours ago
ACADIA Stock Slumps As UBS Slashes Drug Hopes
Yahoo Finance
·
19 hours ago
Top Midday Decliners
The Globe and Mail
·
20 hours ago
Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), ACADIA Pharmaceuticals (ACAD) and Insmed (INSM)
Profile
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, California. Wikipedia
About ACADIA Pharmaceuticals Inc
CEOCatherine Owen Adams
Employees797
Founded1993
HeadquartersSan Diego, California, United States
SectorBiotechnology
Websiteacadia.com